Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B12 (cobalamin) in the rat central nervous system

FASEB Journal

Volumn 13, Issue 14, 1999, Pages 2083-2090

  Scalabrino, Giuseppe ^a   Nicolini, Gabriella ^a   Buccellato, Francesca R ^a   Peracchi, Maddalena ^a   Tredici, Giovanni ^a   Manfridi, Alfredo ^a   Pravettoni, Giulio ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Gife Laboratory   (Switzerland)

Author keywords

Cerebrospinal fluid; Epidermal growth factor; Sub acute combined degeneration; Totally gastrectomized rat

Indexed keywords

CYANOCOBALAMIN; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGENERATIVE DISEASE; GASTRECTOMY; GENE EXPRESSION; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RAT; VITAMIN DEFICIENCY;

ANIMALIA;

EID: 0032723946     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.13.14.2083     Document Type: Article

References (57)

1. Weir, D. G., and Scott, J. M. (1995) The biochemical basis of the neuropathy in cobalamin deficiency. Ballière's Clin. Haemat. 8, 479-497
2. Beck, W. S. (1991) Neuropsychiatric consequences of cobalamin deficiency. Adv. Int. Med 36, 33-56
3. Herbert, V. (1985) Megaloblastic anemias. Lab. Invest. 52, 3-19
4. Metz, J. (1992) Cobalamin deficiency and the pathogenesis of nervous system disease. Annu. Rev. Nutr. 12, 59-79
5. Qureshi, A. A., Rosenblatt, D. S., and Cooper, B. A. (1994) Inherited disorders of cobalamin metabolism. Crit. Rev. Oncol. Hematol. 17, 133-151
6. Chanarin, I., Deacon, R., Lumb, M., and Perry, J. (1992) Cobalamin and folates: Recent developments. J. Clin. Pathol. 45, 277-283
7. Vieira-Makings, E., Chetty, N., Reavis, S. C., and Metz, J. (1991) Methylmalonic acid metabolism and nervous-system fatty acids in cobalamin-deficient fruit bats receiving supplements of methionine, valine and isoleucine. Biochem. J. 275, 585-590
8. Scalabrino, G., Buccellato, F. R., Tredici, G., Morabito, A., Lorenzini, E. C., Allen, R. H., and Lindenbaum, J. (1997) Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. Exp. Neurol. 144, 258-265
9. Scalabrino, G., Buccellato, F. R., and Tredici, G. (1998) Methylmalonic acid as a marker for cobalamin deficiency: fact or fantasy? Elucidations from the cobalamin-deficient rat. Br. J. Haematol. 100, 615-616
10. Scalabrino, G., Monzio-Compagnoni, B., Ferioli, M. E., Lorenzini, E. C., Chiodini, E., and Candiani, R. (1990) Subacute combined degeneration and induction of ornithine decarboxylase in spinal cord of totally gastrectomized rats. Lab. Invest. 62, 297-304
11. Scalabrino, G., Lorenzini, E. C., Monzio-Compagnoni, B., Colombi, R. P., Chiodini, E., and Buccellato, F. R. (1995) Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction. Lab. Invest. 72, 114-123
12. Tredici, G., Buccellato, F. R., Cavaletti, G., and Scalabrino, G. (1998) Subacute combined degeneration in totally gastrectomized rats: an ultrastructural study. J. Submicrosc. Cytol. Pathol. 30, 165-173
13. Tredici, G., Buccellato, F. R., Braga, M., Cavaletti, G., Ciscato, P., Moggio, M., and Scalabrino, G. (1998) Polyneuropathy due to cobalamin deficiency in the rat. J. Neurol. Sci. 156, 18-29
14. Powers, J. (1996) Pathology of myelin. Mol. Chem. Neuropathol. 27, 31-38
15. Buccellato, F. R., Miloso, M., Braga, M., Nicolini, G., Morabito, A., Pravettoni, G., Tredici, G., and Scalabrino, G. (1999) Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated. FASEB J. 13, 297-304
16. Kordek, R., Nerurkar, V. R., Liberski, P. P., Isaacson, S., Yanagihara, R., and Gajdusek, D. C. (1996) Heightened expression of tumor necrosis factor α, interleukin 1α, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. USA 93, 9754-9758
17. Morganti-Kossmann, M. C., Kossmann, T., and Wahl, S. M. (1992) Cytokines and neuropathology. Trends Pharmacol. Sci. 13, 286-291
18. Merrill, J. E., and Benveniste, E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338
19. Rothwell, N. J. (1997) Neuroimmune interactions: the role of cytokines. Br. J. Pharmacol. 121, 841-847
20. Connor, B., and Dragunow, M. (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Rev. 27, 1-39
21. Snider, W. D., and Johnson, E. M., Jr. (1989) Neurotrophic molecules. Ann. Neurol. 26, 489-506
22. Yuen, E. C., and Mobley, W. C. (1996) Therapeutic potential of neurotrophic factors for neurological disorders. Ann. Neurol. 40, 346-354
23. Labourdette, G., and Sensenbrenner, M. (1995) Growth factors and their receptors in the central nervous system. In Neuroglia (Kettenmann, H., and Ranson, B. R., eds) pp. 441-459, Oxford University Press, New York
24. Plata-Salamàn, C. R. (1991) Epidermal growth factor and the nervous system. Peptides 12, 653-663
25. Mazzoni, I. E., and Kenigsberg, R. L. (1992) Effects of epidermal growth factor in the mammalian central nervous system: its possible implications in brain pathologies and therapeutic applications. Drug Dev. Res. 26, 111-128
26. Hefti, F. (1997) Pharmacology of neurotrophic factors. Annu. Rev. Pharmacol. Toxicol. 37, 239-267
27. Yamada, M., Ikeuchi, T., and Hatanaka, H. (1997) The neurotrophic action and signalling of epidermal growth factor. Prog. Neurobiol. 51, 19-37
28. Muller, J. M., Lelievre, V., Becq-Giraudon, L., and Meunier, A. C. (1995) VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment. Mol. Neurobiol. 10, 115-134
29. Said, S. I. (1996) Molecules that protect: the defense of neurons and other cells. J. Clin. Invest. 97, 2163-2164
30. Gressens, P., Marret, S., Hill, J. M., Brenneman, D. E., Gozes, I., Fridkin, M., and Evrard, P. (1997) Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J. Clin. Invest. 100, 390-397
31. Brenneman, D. E., Hill, J. M., Glazner, G. W., Gozes, I., and Phillips, T. W. (1995) Interleukin-1 alpha and vasoactive intestinal peptides: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci 13, 187-200
32. Krisch, B., and Mentlein, R. (1994) Neuropeptide receptors and astrocytes. Int. Rev. Cytol. 148, 119-169
33. Kar, S., and Quirion, R. (1995) Neuropeptide receptors in developing and adult rat spinal cord: an in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, μ-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors. J. Comp. Neurol. 354, 253-281
34. Martin, D. L. (1992) Synthesis and release of neuroactive substances by glial cells. Glia 5, 81-94
35. Hökfelt, T., Johansson, O., Ljungdahl, Å., Lundberg, J. M., and Schultzberg, M. (1980) Peptidergic neurones. Nature (London) 284, 515-521
36. Epelbaum, J. (1986) Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 27, 63-100
37. McMillian, M. K., Thai, L., Hong, J. S., O'Callaghan, J. P., and Pennypacker, K. R. (1994) Brain injury in a dish: a model for reactive gliosis. Trends Neurol. Sci. 17, 138-142
38. Ermisch, A., Brust, P., Kretzschmar, R., and Rühle, H. J. (1993) Peptides and blood-brain barrier transport. Physiol. Rev. 73, 489-527
39. Pant, S. S., Asbury, A. K., and Richardson, E. P., Jr. (1968) The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol. Scand. 44 (Suppl. 35), 8-36
40. Barreca, T., Franceschini, R., Siani, C., Perria, C., Francaviglia, N., Cataldi, A., and Rolandi, E. (1988) Diurnal changes of plasma and cerebrospinal fluid somatostatin and 24-h growth hormone secretory pattern in man. Acta Endocrinol. (Copenh.) 117, 130-134
41. Fischer, D. A., Salido, E. C., and Barajas, L. (1989) Epidermal growth factor and the kidney. Annu. Rev. Physiol. 51, 67-80
42. Williams, M. A. (1977) Preparation of electron microscope autoradiographs. In Practical Methods in Electron Microscopy (Glauert, A. M., ed) Vol. 6, part II, pp. 85-169, North-Holland Publishing Co., Amsterdam, The Netherlands
43. Burgess, A. W. (1989) Epidermal growth factor and transforming growth factor-α. Br. Med. Bull. 45, 401-424
44. Reichlin, S. (1998) Neuroendocrinology. In Williams Textbook of Endocrinology (Wilson, J. D., Foster, D. W., Kronenberg, H. M., and Larsen, P. R., eds) pp. 165-248, W. B. Saunders Co., Philadelphia
45. Wass, J. A. H. (1995) Somatostatin. In Endocrinology (DeGroot, L. J., Besser, M., Burger, H. G., Jameson, J. L., Loriaux, D. L., Marshall, J. C., Odell, W. D., Potts, J. T., Jr., and Rubenstein, A. H., eds) pp. 266-279, W. B. Saunders Co., Philadelphia
46. Peracchi, M., Basilisco, G., Bareggi, B., Quatrini, M., Velio, P., and Bianchi, P. A. (1997) Plasma somatostatin levels in patients with chronic idiopathic intestinal pseudo-obstruction. Am. J. Gastroenterol. 92, 1884-1886
47. Duncan, D. B. (1955) Multiple range and multiple F tests. Biometrics 11, 1-42
48. Swanson, L. W. (1995) Mapping the human brain: past, present, and future. Trends Neurol. Sci. 11, 471-474
49. Morrison, R. S., Kornblum, H. I., Leslie, F. M., and Bradshaw, R. A. (1987) Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor. Science 238, 72-75
50. Han, V. K. M., Smith, A., Myint, W., Nygard, K., and Bradshaw, S. (1992) Mitogenic activity of epidermal growth factor on newborn rat astroglia: interaction with insulin-like growth factors. Endocrinology 131, 1134-1142
51. Huff, K. R., Schreier, W., and Ibric, L. (1990) Proliferation-related responses in rat astrocytes to epidermal growth factor. Int. J. Dev. Neurosci. 8, 255-266
52. Hoffman, M., Schmidt, M., and Wels, W. (1998) Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-α. Cancer Immunol. Immunother. 47, 167-175
53. Pezacka, E. H., Jacobsen, D. W., Luce, K., and Green, R. (1992) Glial cells as a model for the role of cobalamin in the nervous system: impaired synthesis of cobalamin coenzymes in cultured human astrocytes following short-term cobalamin-deprivation. Biochem. Biophys. Res. Commun. 184, 832-839
54. Koli, K., and Keski-Oja, J. (1996) Transforming growth factor-β system and its regulation by members of the steroid-thyroid hormone superfamily. Adv. Cancer Res. 70, 63-94
55. 3 and retinoids. J. Cell. Physiol. 178, 109-119
56. Young, M., Fullerton, M., Dilley, R., and Funder, J. (1994) Mineralocorticoids, hypertension, and cardiac fibrosis. J. Clin. Invest. 93, 2578-2583
57. Young, M., Head, G., and Funder, J. (1995) Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am. J. Physiol. 269, E657-E662